Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Exciting new research into a traditional Indian herb is showing it has the ability to block the spread and invasiveness of cancer cells, potentially leading to an alternative treatment to chemotherapy.
The medicinal herb Bacopa monnieri, known as Brahmi, has been used in Indian medicine for thousands of years, mainly to enhance memory and cognitive function.
However new research at the Basil Hetzel Institute for Translational Health Research (BHI), led by Oncologist Dr Amanda Townsend and Group Leader of Molecular Oncology research, Dr Jennifer Hardingham, has found compounds within the herb, called Bacopasides, can block tumour growth and spread.
Post-doctoral Scientist, Dr Helen Palethorpe, has studied the behaviour of Bacopasides and discovered they can prevent tumour blood vessels from forming and therefore starve tumours of the oxygen and nutrients they need to grow.
“We have also found that Bacopasides cause cell death in breast and colorectal cancer cell lines, and inhibit the migration and invasion of breast cancer mammospheres (3D cultured breast cancer cells),” Dr Palethorpe said.
We are hopeful that Bacopasides will be a safer alternative to standard chemotherapy given that the herb has been used for thousands of years in humans without any untoward toxic effects.
Dr Palethorpe said the work has focused on blocking angiogenesis (the formation of blood vessels in cancer) and tumour invasion.
“These processes cause the tumour cells to metastasise and form cancers in other parts of the body, such as the brain and bone,” she said.
“This is a major cause of breast cancer related deaths so we hope that by blocking angiogenesis and invasion we can prevent breast cancer from spreading.”
The promising research is in its early stages but if further pre-clinical tests continue to be successful, the research can progress to human clinical trials.